Clazosentan in Aneurysmal Subarachnoid Hemorrhage
Clinical trial NCT00940095 · TERMINATED
Trial details
- NCT number
- NCT00940095
- Sponsor
- Idorsia Pharmaceuticals Ltd.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-07-01
- Primary completion
- 2010-10-01
- Enrollment
- 577
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.